Beam Therapeutics, Inc. (BEAM)
26.32
-0.49
(-1.83%)
USD |
NASDAQ |
May 19, 12:35
Beam Therapeutics Research and Development Expense (Quarterly) : 104.52M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 78.54M |
| Twist Bioscience Corp. | 19.70M |
| Recursion Pharmaceuticals, Inc. | 75.20M |
| Anika Therapeutics, Inc. | 6.713M |
| BioCryst Pharmaceuticals, Inc. | 59.26M |